Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process
Clinical trial NCT03922698 · UNKNOWN
Trial details
- NCT number
- NCT03922698
- Sponsor
- Neuromed IRCCS
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-01
- Primary completion
- 2022-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.